| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_decc0a796760683734a8fadd77d831e5 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-006 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-183
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-186
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-137
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0043
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-08 |
| filingDate |
2019-06-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cfc877c4df3ccd668706f37179aa4d5c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0715268bf378cee0857b7022f11b6cf0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_05a042595bb87468813ec50fca37a22e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_01afb9d4df03498a40fcd87c9fca993f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f41097a9a71bc7553bac1489e36d85e9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_934fb3920eca70e9aab970387ebed72d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_946c5acf7ccb53dc78b8c36c66a3f19d |
| publicationDate |
2019-12-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2019241401-A1 |
| titleOfInvention |
Epinephrine spray formulations |
| abstract |
The present invention is directed to epinephrine spray formulations. The present invention is further directed to methods of treating anaphylaxis by administering epinephrine spray formulations to subjects in need of such treatments. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11737980-B2 |
| priorityDate |
2018-06-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |